Skip to content
Linkedin Twitter

COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
COVID-19 Briefings

Free COVID-19 STAT Intelligence Briefings Email Digest

Subscribe Now!
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
Linkedin Twitter

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

Day: November 30, 2020

Second Monoclonal Antibody Treatment for COVID-19 Authorized for Treatment of Mild to Moderate Infections

FDA maze of regulations

Recent developments in emergency use authorizations for investigational therapies for use in the treatment of mild to moderate COVID-19.

HHS Launches Pilot Program Examining the Use of Integrating Rapid Molecular COVID-19 Test Into Existing Testing Strategies

national-testing-strategy-SARS-CoV-2-coalition

HHS Cue pilot program creates hybrid COVID-19 testing strategy, potentially fast tracks Cue into institutions and communities outside of five-state rollout.

Clinical Laboratories May Benefit as Some Nursing Homes Hesitate to Implement Point of Care COVID-19 Antigen Testing

Mass nursing home testing begins in hotspots after HHS device distribution

Nov. 2, 2020, marks the third and final wave of rapid COVID-19 testing device distribution (to about 1,360 nursing homes), according to CMS. Chilly nursing home response may create opportunities for clinical labs.

More COVID-19 Coverage Can Be Found in THE DARK REPORT
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed

Copyright 2020 © The Dark Report. All rights reserved. The Dark Intelligence Group • 21806 Briarcliff Dr • Spicewood, TX 78669

  • Phone: 512-264-7103
Linkedin Twitter